ARCH Venture Management, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
AV ARCH Venture Management, LLC | Institutional Filer | ▲ 3.90% | $677.1M | 10 |
Current Portfolio Holdings
Showing all 10 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | MAZE | Maze Therapeutics, Inc. | Healthcare | 4.1M | $123.0M | 18.16% |
| 2 | RAPP | Rapport Therapeutics, Inc. Common Stock | Healthcare | 3.7M | $116.7M | 17.23% |
| 3 | VIR | Vir Biotechnology, Inc. | Healthcare | 12.9M | $115.7M | 17.09% |
| 4 | ERAS | Erasca, Inc. | Healthcare | 7.1M | $114.7M | 16.95% |
| 5 | BEAM | Beam Therapeutics Inc. | Healthcare | 4.5M | $108.2M | 15.98% |
| 6 | LYEL | Lyell Immunopharma, Inc. | Healthcare | 3.2M | $65.1M | 9.62% |
| 7 | NaN | GENERATE BIOMEDICINES INC | — | 1.9M | $24.3M | 3.59% |
| 8 | TXG | 10x Genomics, Inc. | Healthcare | 218K | $4.6M | 0.68% |
| 9 | GOSS | Gossamer Bio, Inc. | Healthcare | 8.1M | $2.6M | 0.39% |
| 10 | QTTB | Q32 Bio Inc. | Healthcare | 320K | $2.1M | 0.30% |
Showing 1 to 10 of 10 holdings